Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00167921
Status:
COMPLETED
Last Update Posted:
2007-05-28
First Post:
2005-09-09
Brief Title:
Study Comparing Premarin Vaginal Cream Versus Premarin Oral Tablets in Atrophic Vaginitis
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
A Multiple-Dose Comparative Bioavailability Study of Premarin Vaginal Cream Versus Premarin Oral Tablets in Postmenopausal Women With Atrophic Vaginitis
Status:
COMPLETED
Status Verified Date:
2007-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to characterize the systemic exposure and bioavailability at steady state of Premarin Vaginal Cream compared with Premarin oral tablets in postmenopausal women with atrophic vaginitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None